The world’s most extensive Drugs of Abuse Test Menu
![Drugs of Abuse](https://www.randox.com/wp-content/uploads/2018/11/Drug-Image.jpg)
Randox Toxicology offers the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to the ever-changing market influences and develop assays for current and novel drugs trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
DoA II | ||
Buprenorphine | Ketamine | Oxycodone I |
Creatinine | LSD | Oxycodone II |
Fentanyl | MDMA | Propoxyphene |
Generic Opioids | Methaqualone | – |
The Evidence Series of immunoassay analysers are powered by Biochip Array Technology and combine the latest technological advances for drug residue detection using immunoassay principles. The Drugs of Abuse II panel is available for both the Evidence and the Evidence Investigator analysers. The Evidence has a throughput of 90 samples per hour, testing up to 44 tests per sample. The Evidence is a fully automated batch immunoanalyser, allowing for 3960 tests per hour, while the Evidence Investigator is a semi-automated, bench top analyser with testing capabilities of 2376 tests in 70 minutes.
![tox icon1](https://www.randox.com/wp-content/uploads/2018/11/tox-icon1.png)
![tox icon2](https://www.randox.com/wp-content/uploads/2018/11/tox-icon2.png)
To find out more about our Biochip Array Technology and our Evidence Series analysers, visit www.randoxtoxicology.com, or email us at info@randoxtoxicology.com